QA: Balchem CORP in us_medicinal_products/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2014_Balchem_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, Balchem CORP

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 35,753,000
2 remainder_Liabilities 9,761,000
3 AssetsCurrent 277,774,000
4 AssetsNoncurrent 541,000
5 PropertyPlantAndEquipmentNet 54,916,000
6 Goodwill 43,641,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 267,949,000
9 ResearchAndDevelopmentExpense 3,622,000
10 remainder_Expenses 20,968,000
11 remainder_Revenues 337,173,000
12 remainder_NetIncome 240,000
13 remainder_ComprehensiveNetIncome 957,000
  yvar yval
0 Liabilities 45,514,000
1 Assets 376,872,000
2 Expenses 292,539,000
3 Revenues 337,173,000
4 StockholdersEquity 331,358,000
5 NetIncome 44,874,000
6 ComprehensiveNetIncome 45,352,500
7 BaseVar 526,647,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.36
9 EconomicCapitalRatio 2.61

Edgar->Model Mapping

Feature Distribution

Change over Time